Gabriele Bauer
Impact in
- Pharmacology top 0.5%
- Pharmacological Effects of Natural Compounds
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Viral gastroenteritis research and epidemiology
Papers in
-
- COVID-19 Clinical Research Studies 4
- SARS-CoV-2 and COVID-19 Research 4
- Viral gastroenteritis research and epidemiology 2
-
- Retinal Development and Disorders 1
- Co-authors
- Holger F. Rabenau (5 shared papers)J Cinátl (2 shared papers)Doerr Hw (1 shared paper)Hans Wilhelm Doerr (2 shared papers)Jindřich Činátl (3 shared papers)Wolfgang Preiser (3 shared papers)Björn Falkenburger (1 shared paper)Tobias Moser (1 shared paper)
- Journals
- The Lancet (2 papers)Biologicals (1 paper)Cellular and Molecular Life Sciences (1 paper)Annals of the New York Academy of Sciences (1 paper)Medical Microbiology and Immunology (1 paper)
- Partner nations
- GermanySouth AfricaSwitzerland
In The Last Decade
Gabriele Bauer
8 papers receiving 1.8k citations
Gabriele Bauer's Hit Papers
Peers
Comparison fields: 5 of 119
- Pharmacology 489
- Infectious Diseases 801
- General Dentistry 63
- Complementary and alternative medicine 208
- Modeling and Simulation 72
Countries citing papers authored by Gabriele Bauer
This map shows the geographic impact of Gabriele Bauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriele Bauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriele Bauer more than expected).
Fields of papers citing papers by Gabriele Bauer
This network shows the impact of papers produced by Gabriele Bauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriele Bauer. The network helps show where Gabriele Bauer may publish in the future.
Co-authors
The 22 scholars most cited alongside Gabriele Bauer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus Hit paper breakdown → | 2003 | 921 |
| 2 | 2004 | 407 | |
| 3 | 2003 | 351 | |
| 4 | 2009 | 64 | |
| 5 | 2004 | 60 | |
| 6 | 2005 | 32 | |
| 7 | 2005 | 30 | |
| 8 | 1972 | 10 | |
| 9 | 1973 | 0 |
About Gabriele Bauer
Gabriele Bauer is a scholar working on Infectious Diseases, Molecular Biology, Pharmacology, Immunology and Cellular and Molecular Neuroscience, having authored 9 papers that have together received 1.9k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (4 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Pharmacological Effects of Natural Compounds (2 papers), Viral gastroenteritis research and epidemiology (2 papers), Metallurgy and Material Forming (1 paper), Retinal Development and Disorders (1 paper), Phytochemistry and Bioactivity Studies (1 paper) and Microbial infections and disease research (1 paper). The work is most often cited by research in Pharmacology (489 citations), Infectious Diseases (801 citations), General Dentistry (63 citations), Complementary and alternative medicine (208 citations) and Modeling and Simulation (72 citations). Gabriele Bauer has collaborated with scholars based in Germany, South Africa and Switzerland. Frequent co-authors include Holger F. Rabenau, J Cinátl, Doerr Hw, Hans Wilhelm Doerr, Jindřich Činátl, Wolfgang Preiser, Björn Falkenburger, Tobias Moser, H. W. Doerr and Jean‐Marc Fritschy. Their work appears in journals such as The Lancet, Biologicals, Cellular and Molecular Life Sciences, Annals of the New York Academy of Sciences and Medical Microbiology and Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.